수련의사들에 대한 제약회사 마케팅의 범위 및 영향
The Scope and Influence of Pharmaceutical Marketing to Medical Trainees in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
제약회사들은 다양한 판촉활동을 통해 수련의사들에게 접근하며 이는 그들의 처방에 영향을 준다. 본 연구는 한국의 수련의사들이 어떤 종류의 판촉활동에 얼마나 노출되어 있는지, 그리고 그러한 활동에 대한 수용 정도가 어떠한지, 그리고 2010년에 시작된 리베이트 쌍벌제에 대한 인식이 어느 정도인지 등을 파악하기 위한 것이다. 2011년 4월 22일 전주에서 열린 전공의 연수강좌에 참석한 4년차 내과 전공의 221명을 대상으로 현장에서 자기 기입식 설문조사를 실시하였다. 제약회사가 제공하는 판촉 활동의 내용에 따라 수련의들의 수용정도는 다양하였다. ‘볼펜, 메모지 등 소품’의 경우는 98.7%가 ‘수용가능’으로 응답한 반면, ‘특정제품을 의국약으로 지정하고 대가로 회식비 지원’은 66.1%가 ‘수용불가’하다고 응답하였다. 응답자의 87.3%가 약품 설명회를 듣고 처방약을 바꾼 경험이 있었다. 제약회사의 약품설명회가 임상적으로 도움이 되는 정도는 2.97점(/5점)이라고 응답하였다. 리베이트 쌍벌제에 대해서는 ‘충분히 숙지하고 있다’는 응답이 14.7%에 불과하였다. 수련의국 내에 제약회사와의 관계 윤리규정을 가지고 있는 경우는 11.2%였고, 수련기간 중 관련 교육을 받아본 경우도 9.5%뿐이었다. 한국의 수련의들은 다양한 제약 관련 판촉활동에 노출되어 있다. 수련프로그램에 제약회사 관련 윤리 규정이나 교육프로그램은 수련의들의 비판적 윤리의식을 고취시키기 위해 꼭 필요하다.
Abstract
The pharmaceutical industry, through its various marketing activities, has a significant presence among trainees in medical residency and appears to influence their prescribing behavior. The purpose of this study was to assess the extent to which Korean medical trainees are exposed to pharmaceutical promotional activities, how they respond to such activities, and whether they are aware of the ‘dual-punishment law' that came into effect in 2010. An on-the-spot survey was conducted using a questionnaire given to 238 chief residents of internal medicine that participated in educational lectures at Jeonju, South Korea on April 22, 2011. Whether or not trainees accepted promotional activities was found to depend on the nature of the activities in question: 98.7% of trainees thought that it was acceptable to receive office supplies such as ball-point pens and notes; 66.1% found it unacceptable to receive monetary compensation for group dinners in return for designating a particular drug for use; 87.3% answered that they had changed their choice of prescription after being briefed on drugs. A mere 14.7% of trainees claimed to be aware of the “dual-punishment law,” only 11.2% had an ethical code regarding relationships with pharmaceutical companies within their medical communities, and a mere 9.5% of trainees had received any education on such matters. The influence of pharmaceutical promotional activities is widespread among medical trainees in Korea. Residency programs can benefit from policies and curricula that educate residents on the influence that pharmaceutical companies can have on them and the ways in which the information these companies present can be evaluated critically.
참고문헌 (29)
- Reeder M, "Pharmaceutical representatives and emergency medicine residents: a national survey", Ann Emerg Med, 22(10), pp.1593~1596 (1993)
- Hodges B, "Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks", CMAJ, 153(5), pp.553~559 (1995)
- Aldir RE, "Practicing and resident physicians' views on pharmaceutical companies", J Contin Educ Health Prof, 16, pp.25~32 (1996)
- Ferguson RP, "Encounters with pharmaceutical sales representatives among practicing internists", Am J Med, 107(2), pp.149~152 (1999)
- 정유석, "의대생", 전공의와 제약회사의 윤리적 관계, 2011, pp.14(2), 215~223[DOI]
- 고윤석, "한 대학병원에 근무하는 전공의들의 의료윤리 교육에 관한 경험 및 인식도 조사", 한국의료윤리학회지, 10(2), pp.109~116 (2007), 한국의료윤리학회
- "리베이트 공보의, 뇌물죄 적용'징역형' 선고" (2014), 데일리메디[URL]
- Institute of Medicine, "Conflict of interest in medical research, education, and practice" (2009), The National Academies Press
- Steinman MA, "Of principles and pens : attitudes and practices of medicine housestaff toward pharmaceutical industry promotions", Am J Med, 110(7), pp.551~557 (2001)
- Madhavan S, "The gift relationship between pharmaceutical companies and physicians : an exploratory survey of physicians", J Clin Pharm Ther, 22(3), pp.207~215 (1997)
- Halperin EC, "A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers", Int J Radiat Oncol Biol Phys, 59(5), pp.1477~1483 (2004)
- Morgan MA, "Interactions of doctors with the pharmaceutical industry", J Med Ethics, 32(10), pp.559~563 (2006)
- Ziegler MG, "The accuracy of drug information from pharmaceutical sales representatives", JAMA, 273(16), pp.1296~1298 (1995)
- 이홍연, "제약회사 마케팅 인쇄물의 정확도에 대한 평가", 한국의료윤리학회지, 15(2), pp.258~269 (2012), 한국의료윤리학회
- Watkins C, "Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study", BMJ, 326(7400), pp.1178~1179 (2003)
- McCormick BB, "Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior", JAMA, 286(16), pp.1994~1999 (2001)
- Coleman D, "Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach", Acad Med, 81(2), pp.154~160 (2006)
- "Policy and Guidelines for Interactions between the Stanford University School of Medicine, the Stanford Hospital and Clinics, and Lucile Packard Children's Hospital with the Pharmaceutical, Biotech, Medical Device, and Hospital and Research Equipment and Supplies Industries ('Industry')" (2006)[URL]
- "Guidelines for Interactions between Healthcare Professionals and Industry" (2008)[URL]
- Randall ML, "Attitudes and behaviours of psychiatry residents toward pharmaceutical representatives before and after an educational intervention", Acad Psychiatry, 29(1), pp.33~39 (2005)
- Schneider JA, "Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention", Acad Med, 81(7), pp.595~602 (2006)
- Agrawal S, "A prospective before and after trial of an educational intervention about pharmaceutical marketing", Acad Med, 79(11), pp.1046~1050 (2004)
- Shaughnessy AF, "Teaching information mastery: evaluating information provided by pharmaceutical representatives", Fam Med, 27(9), pp.581~585 (1995)
- Hopper JA, "Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives", J Gen Intern Med, 12(10), pp.639~642 (1997)
- Brotzman GL, "The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities", J Gen Intern Med, 8(34), pp.130~134 (1993)
- "Code on Interactions with Healthcare Professionals PhRMA 2008, effective 2009"[URL]
- 이일학, "의료인-제약산업 관계의 이해상충과 윤리적 원칙", 한국의료윤리학회지, 14(2), pp.193~201 (2011), 한국의료윤리학회
- 홍진표, "의사-제약회사 상호작용이 처방에 미치는 영향", 한국의료윤리학회지, 14(2), pp.203~213 (2011), 한국의료윤리학회
- "공정경쟁규약" (2014), 다국적의약산업협회[URL]